Literature DB >> 6660850

High-pressure liquid chromatographic quantitation of azlocillin.

A Weber, K E Opheim, K Wong, A L Smith.   

Abstract

We describe a rapid, precise, and simple procedure for the quantitation of azlocillin in serum and in aqueous solutions by high-pressure, reverse-phase liquid chromatography. This method uses a single precipitation step, detection by dual-wavelength monitoring (220 and 254 nm), and quantitation by comparison with an internal standard. The 10-micron C18 muBondapak column was eluted with 45% (vol/vol) methanol-65% (vol/vol) phosphate buffer. The precision was 4.2 and 5.6% at 50 and 10 micrograms/ml, respectively. The assay was linear up to concentrations of 100 micrograms/ml, with recoveries of 90.4 to 110.5% from serum. The assay was sensitive to 0.4 micrograms of azlocillin per ml. The short turnover time (14 min) and small serum sample size (20 microliters) make the assay ideal for therapeutic drug monitoring and clinical pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660850      PMCID: PMC185937          DOI: 10.1128/AAC.24.5.750

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  [Clinical results with azlocillin (author's transl)].

Authors:  P Schacht; D Tettenborn; R Hullmann; H Bruck
Journal:  Arzneimittelforschung       Date:  1979

2.  Azlocillin and mezlocillin, two new alpha-amino-substituted penicillins. A comparison of the in vitro activity with other penicillins.

Authors:  R Wise
Journal:  Arzneimittelforschung       Date:  1979

3.  Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics.

Authors:  D S Reeves; M J Bywater; H A Holt; J M Broughall
Journal:  Arzneimittelforschung       Date:  1979

4.  Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.

Authors:  J Tselentis; T Cordossis; J Kosmidis; S Lambropoulos; K Melissinos
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

5.  Azlocillin: in vitro studies of a new semisynthetic penicillin.

Authors:  D Stewart; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

6.  Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.

Authors:  L Coppens; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.

Authors:  G K Daikos; H Giamarellou; K Hadjipolydorou; K Kanellakopoulou
Journal:  Arzneimittelforschung       Date:  1979

8.  [High pressure liquid chromatographic analysis of azlocillin and its penicilloate in urine].

Authors:  W Gau; F A Horster
Journal:  Arzneimittelforschung       Date:  1979

9.  Treatment with azlocillin in complicated urinary tract infections.

Authors:  O Alfthan; O V Renkonen; H Ohlsson
Journal:  Arzneimittelforschung       Date:  1979

10.  Microbioassay of antimicrobial agents.

Authors:  H J Simon; E J Yin
Journal:  Appl Microbiol       Date:  1970-04
View more
  3 in total

1.  Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.

Authors:  R D Lander; R P Henderson; D R Pyszczynski
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Determination of mezlocillin and its penicilloate and penilloate by high-performance liquid chromatography and stability of mezlocillin at different temperatures.

Authors:  J Knöller; K D Bremm; W Schönfeld; W König
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

3.  Improved micromethod for mezlocillin quantitation in serum and urine by high-pressure liquid chromatography.

Authors:  D Fiore; F A Auger; G L Drusano; V R Dandu; L J Lesko
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.